Yeh, Kuo-Wei , M.D.
Intitution:Linkou Chang Gung Memorial Hospital / Chang Gung University
Position:
Director of Division of Allergy Asthma and Rheumatology of Department of Pediatrics;
Associate Professor in Department of Pediatrics in Chang Gung Children’s Hospital and Chang Gung University
Department: Department of Pediatric Allergy Immunology Asthma Rheumatology
Address:No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel:+886-3-3281200
Fax: +886-3-3288957
E-mail: kwyeh@adm.cgmh.org.tw,kjaecqaa@gmail.com
Focus of Interest:
1982-1986 -- Division of Occupational Therapy, Department of Rehabilitation, National Taiwan University, Taipei, Taiwan
1987-1992-- Department of Post-Graduate Medicine, Chang Gung Medical College, Taoyuan, Taiwan
August 1997- July 1998 : Research fellow in Immunopharmacology Group of Southampton General Hospital, Southampton, UK
Employment Records:
July 1992 - June 1995 : Resident, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
July 1995 - July 1997 : Fellow in Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, Taoyuan, Taiwan
July 1997 - :Attending Physician in Division of Asthma, Allergy and rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, Taoyuan, Taiwan
Honors and Awards:
2007 Distinguished Alumni of Chang Gung University
2009 Evidence-based Medicine Competition-Clinical application –Silver Medal
Selected Main Publications:
Board Certification on Taiwan Pediatric Association
Board Certification on The Chinese Society of Immunology
Board Certification on The Taiwan Academy of Pediatric Allergy, Asthma Rheumatology and Immunology
Professional Activities:
Deputy Secretary General of Taiwan Pediatric Association (2014.5~)
Secretary General of Taiwan Asthma Council Society (2013.4~)
Secretary General of Taiwan Academy of Pediatric Allergy Asthma and Immunology (2011,9~)
Secretary General of the Chinese Society of Immunology (2008~2012)
International Fellow of American Academy of Allergy, Asthma and Immunology
Ongoing projects:
The natural development of allergic disease in Keelung-A birth cohort study II oxidative stress and allergy
A 6-month safety and benefic study of inhaled fluticasone propionate/salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatrics subjectss4-11 years old with persistent asthma
A phase III, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability pf Lebrikizumab in adolescent patients with uncontrolled asthma who are on inhaled corticosteroid and a second controller medication
Intitution:Linkou Chang Gung Memorial Hospital / Chang Gung University
Position:
Director of Division of Allergy Asthma and Rheumatology of Department of Pediatrics;
Associate Professor in Department of Pediatrics in Chang Gung Children’s Hospital and Chang Gung University
Department: Department of Pediatric Allergy Immunology Asthma Rheumatology
Address:No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel:+886-3-3281200
Fax: +886-3-3288957
E-mail: kwyeh@adm.cgmh.org.tw,kjaecqaa@gmail.com
Focus of Interest:
- Pediatric Medicine
- Allergy
- Rheumatology
1982-1986 -- Division of Occupational Therapy, Department of Rehabilitation, National Taiwan University, Taipei, Taiwan
1987-1992-- Department of Post-Graduate Medicine, Chang Gung Medical College, Taoyuan, Taiwan
August 1997- July 1998 : Research fellow in Immunopharmacology Group of Southampton General Hospital, Southampton, UK
Employment Records:
July 1992 - June 1995 : Resident, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
July 1995 - July 1997 : Fellow in Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, Taoyuan, Taiwan
July 1997 - :Attending Physician in Division of Asthma, Allergy and rheumatology, Department of Pediatrics, Chang Gung Children’s Hospital, Taoyuan, Taiwan
Honors and Awards:
2007 Distinguished Alumni of Chang Gung University
2009 Evidence-based Medicine Competition-Clinical application –Silver Medal
Selected Main Publications:
- Yeh KW, Lee CM, Chang CJ, Lin YR and Huang JL. Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-alpha treatment. PLOS ONE 2014; 9(3)e90757
- Yeh KW, YuCH,Chan PC, HorngJT, Huang JL. Burden of systemic lupus erythematosus in Taiwan:a population-based survey. Rheumatol Int. 2013;33:1805-11
- Shen CC, Yao TC, Yeh KW*. Huang JL*. Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: A prospective study. Semin Arthritis Rheum. 2013 ;42:590-6.
- Yao TC, Tsai HJ, Tu YL, Chang SW, Hua MC, Liao SL, Tsai MH, Chiu CY, Lai SH, Yeh KW, Huang JL. Multoplexed Immunoglobin E sensitization is relation to nitric oxide in a population sample of children. Allergy 2014; 69:678-82
- Liao SL, Lai SH, Yeh KW, Hwa MC, Tsai MH, Huang JL. Exclusive breastfeeding is associated with reduced sensitization to cow’s milk protein during early childhood: a prospective cohort study. Pediatr Allergy Immunol 2014
Board Certification on Taiwan Pediatric Association
Board Certification on The Chinese Society of Immunology
Board Certification on The Taiwan Academy of Pediatric Allergy, Asthma Rheumatology and Immunology
Professional Activities:
Deputy Secretary General of Taiwan Pediatric Association (2014.5~)
Secretary General of Taiwan Asthma Council Society (2013.4~)
Secretary General of Taiwan Academy of Pediatric Allergy Asthma and Immunology (2011,9~)
Secretary General of the Chinese Society of Immunology (2008~2012)
International Fellow of American Academy of Allergy, Asthma and Immunology
Ongoing projects:
The natural development of allergic disease in Keelung-A birth cohort study II oxidative stress and allergy
A 6-month safety and benefic study of inhaled fluticasone propionate/salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatrics subjectss4-11 years old with persistent asthma
A phase III, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability pf Lebrikizumab in adolescent patients with uncontrolled asthma who are on inhaled corticosteroid and a second controller medication